Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Actavis Inc    

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 16 755 M
EBIT 2016 7 815 M
Net income 2016 -193 M
Debt 2016 14 510 M
Yield 2016 -
Sales 2017 18 281 M
EBIT 2017 8 951 M
Net income 2017 923 M
Debt 2017 9 057 M
Yield 2017 -
P/E ratio 2016 529,88
P/E ratio 2017 79,11
EV / Sales 2016 6,24x
EV / Sales 2017 5,43x
Capitalization 90 128 M
More Financials
Company
Allergan Plc engages in the research, development, and manufacture of pharmaceutical products.The firm offers products under the following brands: BOTOX, Juvederm, Linzess, Namenda, Restasis, Latisse, Teflaro, Lo Loestrin Fe, Bystolic, DORYX, Saphris, Fetzima, Namenda XR, Namzaric, Viberzi,... 
Sector
Pharmaceuticals
Calendar
06/02 | 10:00pmPresentation
More about the company
Surperformance© ratings of Actavis Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACTAVIS INC
05/24DJOCI : Tax Rule Scuppers $8 Billion Deal -- WSJ
05/23DJOCI : CF, OCI Ditch Merger, Citing New U.S. Tax Rules--2nd Update
05/23 Allergan CEO says company is 'weeks away' from closing Teva deal
05/23DJJOHNSON & JOHNSON : Ex-Health Executives Go on Trial -- WSJ
05/23DJOCI : CF, OCI Ditch Merger, Citing New U.S. Tax Rules--2nd Update
05/17DJPfizer Buys Anacor In Turn to Smaller Deals -- WSJ
05/16DJPfizer to Buy Anacor for $4.5 Billion--2nd Update
05/16DJPfizer to Buy Anacor for $4.5 Billion--Update
More news
Sector news : Pharmaceuticals - NEC
05:01p MYLAN NV : to Present at Goldman Sachs 37th Annual Global Healthcare Conference
04:39p PFIZER : Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare ..
03:35pDJIonis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions